David Henry Mack
President and CEO at PMV Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: PMV Pharmaceuticals Inc., 3 years.
PMV Pharmaceuticals Inc.
Director · President and CEO
Chief executive roles
PMV Pharmaceuticals Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 27, 2025 | PMV Pharmaceuticals Inc. | Option exercise | +220,643 | $1.37 | $302,281 |
| Jul 1, 2025 | PMV Pharmaceuticals Inc. | Open-market sale | −58,411 | $1.06 | $61,916 |
| Jan 3, 2025 | PMV Pharmaceuticals Inc. | Option exercise | +17,709 | $0.53 | $9,386 |
| Dec 3, 2024 | PMV Pharmaceuticals Inc. | Option exercise | +91,750 | $0.53 | $48,628 |
| Jan 18, 2024 | PMV Pharmaceuticals Inc. | Grant or award | +163,890 | — | — |
| Nov 10, 2023 | PMV Pharmaceuticals Inc. | Gift | −85,307 | — | — |
| Nov 10, 2023 | PMV Pharmaceuticals Inc. | Gift | +85,307 | — | — |
| Oct 18, 2023 | PMV Pharmaceuticals Inc. | Option exercise | +198,407 | $0.53 | $105,156 |
| Aug 7, 2023 | PMV Pharmaceuticals Inc. | Option exercise | +85,500 | $0.53 | $45,315 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.